Resources
- sort by:
- Relevance
- Date
- Popularity
- FDA uncovers flaws in Norvir brochures
- THE FDA has taken issue with certain patient information materials that Abbott Laboratories is using to market its AIDS drug Norvir, specifically that Norvir is the lowest-cost protease inhibitor. Protease inhibitors are key components of drug "cocktails" used to treat HIV.
- Research articles 2004-07-01
- Gov't: Abbott patent to stand.(Briefs)(Abbott Laboratories Inc.)(Brief Article)
- The government refused to override patents on North Chicago-based Abbott Laboratories' AIDS drug Norvir, effectively allowing a quintupling of the price to stand despite consumer groups' accusations of price gouging. Patient groups and some members o The government refused to override patents on North Chicago-based ...
- Research articles 2004-08-09
- Is There Really a "Market Price" for Drugs?
- Everyone seems to be ganging up on high drug prices these days. In two separate hearings last week, Congressional committees took after drugmakers for big markups on specialty treatments and a pharma "windfall" created by the Medicare prescription-drug benefit, while the WSJ took a hard look at the opacity of...
- Blog posts 2008-07-27
- Essential Inventions on NIH Decision to Hold Public Meeting on Compulsory Licenses Remedy for Abbott Abuse of Ritonavir Patents
- WASHINGTON, May 3 /U.S. Newswire/ -- The following is a statement of Essential Inventions on the decision by the National Institutes of Health NIH to hold a public meeting on compulsory licenses remedy for Abbott abuse of Ritonavir trade name Norvir pWASHINGTON, May 3 /U.S. Newswire/ -- The following is...
- Research articles 2004-05-03
- Abbott Labs' "Position of Strength" May Not Be as Strong as It Looks
- Figuring out whether Abbott Laboratories is firing on all cylinders or heading for a wall is a complicated business. On the one hand, the company announced it would lay off 1,000 employees in its diagnostics business. Abbott spokesperson Melissa Brotz said: We are taking this action...
- Blog posts 2008-08-26
- Why Abbott Is Allowed to Manipulate GSK and BMS's AIDS Drug Prices
- Here's an explanation of how Abbott, which has a monopoly on Norvir, is now allowed as a matter of law to continue to rig prices of GlaxoSmithKline's Reyataz and Bristol-Myers Squibb's Lexiva. by Jim Edwards
- Blog posts 2009-07-08
- Abbott Q3: How a Monopoly Over an HIV Drug Resulted in Lower Sales
- A court decision recently put a stamp of approval on Abbott's monopoly over Norvir, a protease inhibitor that functions as a booster for its HIV drug, Kaletra. But that now-legal monopoly has not resulted in increased sales, according to Abbott's Q3 2009 earnings report. by Jim Edwards
- Blog posts 2009-10-14
- << Previous
- page 1 of 1
- Next >>
Presented by American Express